Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
1.
Springerplus ; 5(1): 1652, 2016.
Article in English | MEDLINE | ID: mdl-27722069

ABSTRACT

The University of Cape Town Karl Storz Head and Neck Surgery Fellowship is the only head and neck surgery fellowship in Sub-Saharan Africa. This article briefly describes this fellowship and outlines the experience and ongoing collaborative efforts of members of the American Academy of otolaryngology-head and neck surgery with graduates of this program who are now building head and neck surgery programs in East Africa. This educational collaboration avoids many common pitfalls associated with short-term humanitarian outreach and represents a successful model for international collaborative educational efforts with head and neck surgeons in developing countries in Africa.

2.
J Laryngol Otol ; 122(5): 437-41, 2008 May.
Article in English | MEDLINE | ID: mdl-17892603

ABSTRACT

Accepted concepts of the pathophysiology and treatment of laryngeal paralysis have changed over the years. It has long been observed that symptoms of laryngeal paralysis vary greatly, both between patients and over time. There have been various theories to explain these differences. This article reviews how these ideas have changed over time as research has produced new information. Currently, the most popular view is that the laryngeal nerve regenerates after injury, albeit incompletely and inconsistently, and that variations in symptoms and laryngeal posture can be accounted for by muscle activity.


Subject(s)
Laryngeal Nerves/physiopathology , Laryngoscopy/methods , Nerve Regeneration/physiology , Vocal Cord Paralysis/diagnosis , Animals , Cats , Dogs , Humans , Laryngeal Muscles/innervation , Laryngeal Muscles/physiopathology , Laryngoscopy/standards , Vocal Cord Paralysis/complications , Vocal Cord Paralysis/physiopathology , Vocal Cord Paralysis/surgery
3.
Otolaryngol Clin North Am ; 33(4): 895-904, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10918667

ABSTRACT

Neurolaryngology is the study and management of disorders that impair neural control of the larynx and pharynx in breathing, swallowing, and speech. Advances in functional endoscopy and fluoroscopy and increased understanding of neurophysiology have greatly facilitated the development of this discipline. The empiric observations of effective therapies have been equally important, however. In comparison to other fields of medicine, neurolaryngology is a relatively young discipline, and much remains to be discovered and developed.


Subject(s)
Neurology , Otolaryngology/trends , Terminology as Topic , Humans
4.
Ann Otol Rhinol Laryngol ; 109(4): 360-4, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10778889

ABSTRACT

In flaccid laryngeal paralysis, the vocal process (VP) is displaced laterally and superiorly. The arytenoid adduction procedure (AA) moves the VP medially and caudally, closing the glottic gap. However, clinical evidence suggests that the VP is more caudal after AA than in physiological phonation. The neurally intact arytenoid is supported by tonic and phonatory activity of the posterior cricoarytenoid muscle (PCA). We hypothesize that a posterior anchoring suture could replace PCA support, achieving a more natural VP location. Cadaver larynges were scanned with computed tomography at rest and after AA, alone or in combination with a second arytenoid suture anchored to either the posterior midline cricoid (PC) or the inferior thyroid cornu (IC). Each posterior suture reduced caudal displacement of the VP during AA, but the glottic gap was wider with the PC suture. In 3 patients undergoing AA for laryngeal paralysis, the IC suture improved arytenoid posture and voice quality.


Subject(s)
Laryngeal Muscles/physiology , Vocal Cord Paralysis/physiopathology , Female , Humans , In Vitro Techniques , Laryngeal Muscles/physiopathology , Laryngoscopy , Movement , Pregnancy
5.
Clin Ther ; 22(12): 1433-42, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11192135

ABSTRACT

BACKGROUND: There have been reports from physicians in clinical practice that up to 30% of patients taking bisphosphonate therapy develop upper gastrointestinal (UGI) symptoms, many or most of which they assume to be related to the drug. However, in several large placebo-controlled clinical trials of bisphosphonates, the incidence of UGI symptoms has been > or =30%, even among patients receiving placebo, perhaps reflecting a high background incidence of UGI events in osteoporotic patients. OBJECTIVE: To assess the relationship between alendronate treatment and UGI complaints in patients who had discontinued treatment with alendronate in clinical practice because of UGI symptoms, we compared the incidence of such events on rechallenge with alendronate or placebo. METHODS: This was a multicenter, double-blind trial in which postmenopausal women with osteoporosis who had previously discontinued alendronate therapy because of a UGI adverse experience were randomized to daily treatment with either alendronate 10 mg or matching placebo (1:1 ratio) for 8 weeks. The primary end point was the cumulative incidence of discontinuations due to any UGI adverse experience. Secondary end points were the incidence of any clinical adverse experiences and the percentage change from baseline in urinary N-telopeptide adjusted for urinary creatinine at week 8. RESULTS: A total of 172 women were included in the study. They were a mean of 20.9 years past menopause, ranging in age from 41 to 90 years (mean, 67.0 years); 90.7% were white. On rechallenge, 14.8% (13/88) of patients in the alendronate group and 16.7% (14/84) in the placebo group discontinued treatment because of UGI adverse experiences. CONCLUSION: The results of this study suggest that many UGI adverse experiences reported during therapy with alendronate may reflect a high background incidence of UGI complaints and an increased sensitivity to detection of such complaints, rather than a causal relationship to therapy.


Subject(s)
Alendronate/adverse effects , Digestive System/drug effects , Alendronate/therapeutic use , Collagen/urine , Collagen Type I , Double-Blind Method , Female , Humans , Osteoporosis/drug therapy , Patient Compliance , Peptides/urine , Placebos , Postmenopause
6.
J Clin Densitom ; 3(4): 319-24, 2000.
Article in English | MEDLINE | ID: mdl-11175911

ABSTRACT

T-score discordance is observed when the difference between the hip and spine are sufficient to result in the two measurement sites falling into two different diagnoses as defined by the World Health Organization (WHO) classification system. This article examines the prevalence of patterns of T-score discordance between the total hip and PA L1-L4 total spine sites in 5051 female patients undergoing dual X-ray absorptiometry (DXA) bone density testing at a community-based outpatient osteoporosis testing center between 1989 and 1999. Data for all patients was stored in a relational database that was searched for various combinations of T-scores reflecting the nine possible discordant and concordant permutations of normal, osteopenia, and osteoporosis. The WHO diagnostic classification system for osteoporosis categorizes patients into three diagnoses-normal, osteopenia, or osteoporosis-and is based upon their T-score. This system was used to determine the patient diagnoses for the various T-score results in the PA L1-L4 lumbar spine and total hip. Concordance was defined as present when the spine and hip T-score placed the patient in the same diagnostic class. Minor discordance was defined as present when the difference between two sites is no more than one WHO diagnostic class. Major discordance was defined as present when one site is osteoporotic and the other site is normal. The results showed that in 56% of the cases the T-score concordance was present between the hip and the spine, 39% of the time minor discordance was observed, and 5% of the time major discordance was found. Discordance was also classified into five etiological types: physiologic, pathophysiologic, anatomic, artifactual, and technical. In summary, this data analysis showed that while T-score concordance is most commonly observed, minor discordance is seen in about two out of every five patients tested with DXA between the spine and hip sites. Major discordance was uncommon, being found in only 1 out of every 20 patients tested.


Subject(s)
Absorptiometry, Photon , Bone Density , Hip/physiopathology , Osteoporosis/diagnosis , Spine/physiopathology , Female , Humans
7.
Laryngoscope ; 109(10): 1589-93, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10522926

ABSTRACT

OBJECTIVE: To report outcomes of treatment for laryngeal contact granuloma. STUDY DESIGN: Prospective treatment of 21 patients with laryngeal contact granulomas using proton-pump inhibitor (PPI) medication. METHODS: Patients were diagnosed and followed by office endoscopy and patient interview. RESULTS: Three patients did not tolerate PPI medication and were managed by treatment with type 2 histamine (H2) blockers. The lesion completely resolved in 14 of the 18 patients maintained on PPI medication, and significantly regressed in the other 4. Residual granulomas were surgically excised in one patient. Lesions resolved in two patients following injection of botulinum toxin into one thyroarytenoid muscle. One patient had a residual lesion, but symptoms were controlled by medication, and he declined treatment with botulinum toxin. Of the three patients treated with H2-blocker medication, the lesion resolved in only one. CONCLUSION: PPI medication is effective in the treatment of laryngeal contact granuloma, even in the absence of identifiable symptoms of gastroesophageal reflux.


Subject(s)
Granuloma/drug therapy , Histamine H2 Antagonists/therapeutic use , Laryngeal Neoplasms/drug therapy , Levamisole/therapeutic use , Omeprazole/therapeutic use , Proton Pump Inhibitors , Ranitidine/therapeutic use , Adult , Aged , Anti-Dyskinesia Agents/therapeutic use , Botulinum Toxins/therapeutic use , Female , Humans , Male , Middle Aged , Prospective Studies , Treatment Outcome
8.
Laryngoscope ; 109(5): 694-7, 1999 May.
Article in English | MEDLINE | ID: mdl-10334215

ABSTRACT

OBJECTIVE: Describe a clinical syndrome of laryngeal hypersensitivity following laryngeal nerve injury. STUDY DESIGN: Retrospective review of six patients with laryngeal paralysis sustained during neck surgery who presented with paroxysms of coughing and stridor, progressing to brief episodes of complete airway occlusion. METHODS: Chart review. RESULTS: Superior laryngeal nerve blockade temporarily improved symptoms in four of five patients. Botulinum toxin relieved spasm in two of three patients and reduced symptoms in the third. Symptoms gradually diminished or resolved in four patients from 1 to 2.5 years later. One patient underwent arytenoidectomy and one patient has a tracheostomy. CONCLUSIONS: Patients with laryngeal injury may present with stridor and acute airway obstruction secondary to paroxysmal laryngospasm. The authors have found that superior laryngeal nerve blockade or botulinum toxin may be effective in temporary relief of symptoms.


Subject(s)
Laryngeal Nerve Injuries , Laryngismus/etiology , Vocal Cord Paralysis/complications , Adult , Anti-Dyskinesia Agents/therapeutic use , Botulinum Toxins/therapeutic use , Female , Humans , Laryngismus/drug therapy , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Vocal Cord Paralysis/drug therapy
10.
Muscle Nerve ; 22(1): 111-4, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9883865

ABSTRACT

Single-fiber electromyography (SFEMG) is useful in the evaluation of disorders of neuromuscular transmission and the assessment of motor unit morphology. Standard EMG techniques are used routinely in the evaluation of laryngeal dysfunction, but the feasibility of laryngeal SFEMG has not been established. We, therefore, performed laryngeal SFEMG in 10 normal individuals to demonstrate the feasibility of the technique and generate preliminary normative data. We also studied 2 patients with amyotrophic lateral sclerosis and 1 patient previously treated with botulinum toxin for comparative purposes.


Subject(s)
Electromyography/methods , Laryngeal Muscles/physiology , Adult , Aged , Amyotrophic Lateral Sclerosis/pathology , Amyotrophic Lateral Sclerosis/physiopathology , Botulinum Toxins/therapeutic use , Female , Humans , Laryngeal Muscles/pathology , Male , Middle Aged , Muscle Fibers, Skeletal/pathology , Muscle Fibers, Skeletal/physiology , Muscle Spasticity/drug therapy , Muscle Spasticity/pathology , Muscle Spasticity/physiopathology , Speech Disorders/pathology , Speech Disorders/physiopathology , Synaptic Transmission
11.
J Voice ; 12(3): 335-9, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9763183

ABSTRACT

It is frequently stated that unilateral cricothyroid muscle (CT) paralysis can be diagnosed by physical examination, noting rotation of the glottis, and shortening and vertical displacement of the ipsilateral vocal fold. These signs, however, are inconsistently observed, and there is considerable controversy regarding the direction of glottic rotation. To determine the effects of CT contraction on three-dimensional glottic configuration, we performed computerized tomography on cadaver larynges before and after simulated CT contraction. Radiopaque makers were used to compute distances. Unilateral CT contraction equally increased the length of both membranous vocal folds, and rotated the posterior glottis less than 1 mm. CT contraction neither adducted the vocal processes, nor significantly their altered vertical level. These results suggest that unilateral CT paralysis cannot be diagnosed on the basis of any clinically apparent change in glottal configuration.


Subject(s)
Cricoid Cartilage/innervation , Glottis/anatomy & histology , Muscle Contraction/physiology , Thyroid Gland/innervation , Culture Techniques , Humans , Vocal Cords/physiology
13.
Bone ; 22(6): 695-8, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9626411

ABSTRACT

Antacids containing aluminum and magnesium hydroxide are widely used nonprescription agents for treatment of gastritis and peptic ulcer disease. One of the side effects of these antacids is that they bind phosphate in the gut, resulting in its malabsorption. Short-term use, consistent with the directions on the manufacturer's label, is safe and effective for most patients. Heavy chronic use, even when within label, can cause serious skeletal impairment. This report concerns the case of a 39-year-old pharmacist who self-mediated for peptic ulcer disease with high doses of a potent antacid containing aluminum and magnesium hydroxide. The patient consumed over 18 kg of elemental aluminum and 15 kg of elemental magnesium over 8 years of antacid use. This treatment resulted in the clinical syndrome of severe osteomalacia due to profound phosphate depletion. Bone biopsy revealed stainable aluminum deposits along 27.6% of the total bone surface, which is a unique observation in a patient with normal renal function. Treatment included withdrawing the antacid and supplementation with phosphate, calcium, and vitamin D. She experienced marked subjective and objective improvement with this regimen. This included a striking increase in her bone mineral density occurring over the 2-year follow-up period. This case documents that long-term antacid therapy, even when used by patients with normal renal function and within the manufacturer's label recommendations, can lead to severe phosphate depletion, osteomalacia, and toxic accumulation of aluminum and magnesium. This clinical syndrome was readily treated by withdrawal of the antacid and with calcium and phosphate supplementation. Physicians recommending treatment with these compounds or learning of their patient's self-medication with them should inform the patient of the potential serious side effects these agents can cause when used chronically at maximally recommended doses.


Subject(s)
Aluminum/metabolism , Antacids/adverse effects , Bone Density/drug effects , Kidney/physiology , Magnesium Hydroxide/metabolism , Osteomalacia/chemically induced , Osteomalacia/metabolism , Self Medication/adverse effects , Adult , Bone Density/physiology , Calcium/administration & dosage , Calcium/therapeutic use , Female , Humans , Kidney/drug effects , Osteomalacia/drug therapy , Phosphates/administration & dosage , Phosphates/therapeutic use , Vitamin D/administration & dosage , Vitamin D/therapeutic use
14.
J Voice ; 12(1): 44-9, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9619978

ABSTRACT

Simultaneous measurements of mean airflow rate, vocal intensity and fundamental frequency were made during flexible video endoscopic recording of the vowel /i/ sustained in two vocal registers, modal and falsetto. The glottal closure patterns of four males and four females were evaluated by visually inspecting the video images. Acoustic signals were recorded and analyzed to verify the frequency and intensity criteria. Aerodynamic analysis of mean airflow rate was done via Rothenberg mask and commercial software. Incomplete glottic closure was common in both males and females. The degree of closure was significantly higher for modal samples than for falsetto samples with frequency and intensity held constant. The shape of the glottal closure did not vary with changes in the mode of phonation. As expected, the mean airflow rate increased with decreased glottal closure. The results suggest that incomplete glottic closure should be considered as a normal glottal configuration in high frequency modal and falsetto phonation. Moreover, hourglass and spindle glottal configurations may also be found in both the modal and falsetto registers of normal subjects. These results also confirm the positive relationships between degree of glottal gap and mean airflow rate. Thus, mean airflow rate may be regarded as a criterion for judging degree of glottal closure.


Subject(s)
Phonation/physiology , Vocal Cords/physiology , Voice Quality , Adult , Female , Humans , Male , Middle Aged
15.
Otolaryngol Head Neck Surg ; 118(6): 810-5, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9627242

ABSTRACT

OBJECTIVE: We report the preliminary results of a phase I trial using indole-3-carbinol for the treatment of recurrent respiratory papillomatosis. Indole-3-carbinol is a chemical that is found in high concentrations in cruciferous vegetables and has been shown to alter the growth pattern of recurrent respiratory papillomatosis cell cultures and to be effective in an in vivo animal model of recurrent respiratory papillomatosis. METHODS: Eighteen patients were treated with oral indole-3-carbinol and had a minimum follow-up of 8 months and a mean follow-up of 14.6 months. All patients received indole-3-carbinol, and outcome measures included a change in papilloma growth rate and the need for surgery during treatment compared with before treatment. All patients had serial examinations with videoendoscopy to document papilloma location and growth rate. RESULTS: Thirty-three percent (6 of 18) of the study patients had a cessation of their papilloma growth and have not required surgery since the start of the study. Six patients have had reduced papilloma growth rate, and 6 (33%) patients have shown no clinical response to indole-3-carbinol. Indole-3-carbinol affects the ratio of hydroxylation of estradiol; changes in the ratios of urinary 2-hydroxylation and 16-hydroxylation of estradiol caused by indole-3-carbinol correlated well with clinical response. No major complications or changes in the children's growth curve were noted. CONCLUSIONS: The preliminary results of treating recurrent respiratory papillomatosis with indole-3-carbinol holds promise. Longer follow-up of this patient group and a blinded, controlled trial are required. We conclude that indole-3-carbinol appears to be safe and well tolerated and may be an efficacious treatment for recurrent respiratory papillomatosis.


Subject(s)
Estrogen Antagonists/therapeutic use , Indoles/therapeutic use , Neoplasm Recurrence, Local/drug therapy , Papilloma/drug therapy , Respiratory Tract Neoplasms/drug therapy , Adult , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Prospective Studies , Treatment Outcome
16.
Arch Otolaryngol Head Neck Surg ; 124(5): 589-92, 1998 May.
Article in English | MEDLINE | ID: mdl-9604988

ABSTRACT

OBJECTIVE: To describe the functional outcomes of weight loss and eating following a targeted chemoradiation protocol consisting of a selective supradose of intra-arterial cisplatin (150 mg/m2 per week for 4 weeks) with parenteral sodium thiosulfate and external-beam irradiation (1.8-2.0 Gy per fraction per day for 35 days). SUBJECTS AND DESIGN: Forty-seven patients with advanced head and neck cancer treated with a targeted chemoradiation protocol were monitored for weight and eating status before treatment and as long as 18 months after treatment. RESULTS: A statistically significant weight loss (P<.001) occurred during the targeted chemoradiation protocol, with a mean weight ratio of 90% of the starting weight. The ability to eat also declined, with an increase in reported swallowing difficulties and a need for percutaneous endoscopic gastrostomy tubes from 4 (9%) to 12 (26%). There were no significant changes in weight after the initial weight loss. Tumor stage and nodal involvement had no effect on weight loss. At the start of treatment, 18 patients (38%) reported normal eating and 4 (8%) required a feeding tube. By 18 months after treatment, 41 (87%) were eating normally, 34 (72%) reported normal eating, and 6 (13%) required a percutaneous endoscopic gastrostomy tube. CONCLUSIONS: Patients undergoing a targeted chemoradiation protocol for head and neck cancer lost about 10% of their pretreatment weight and had a decline in eating ability. Difficulty swallowing during the treatment may be due to adverse effects such as mucositis and nausea. By 18 months after therapy, most were able to eat normally and maintain their weight.


Subject(s)
Antineoplastic Agents/therapeutic use , Body Weight , Cisplatin/therapeutic use , Eating , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/radiotherapy , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Cisplatin/administration & dosage , Deglutition Disorders/etiology , Head and Neck Neoplasms/physiopathology , Humans , Infusions, Intra-Arterial , Intubation, Gastrointestinal , Middle Aged , Postoperative Complications , Treatment Outcome
18.
Ann Otol Rhinol Laryngol ; 106(7 Pt 1): 552-5, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9228853

ABSTRACT

Videoendoscopy suggests that arytenoid adduction (AA) surgery not only medializes the paralyzed vocal fold, but increases the length of its membranous portion so that it more closely resembles the normal side. This could represent either real length change or out-of-plane rotation. Computed tomography scanning was performed on adult male cadaver larynges before and after the AA procedure to measure changes in length and spatial orientation of the vocal fold. Three-dimensional coordinates of radiopaque markers on the anterior commissure, posterior glottic midline, and vocal processes were determined. The distance between the vocal processes was 3.9 mm before, and 0.8 mm after AA. The mean vocal fold length was 12.4 mm before, and 13.4 mm after AA (p = .14). The vocal process moved consistently caudally, an average of 3.5 mm (p = .02). The data suggest that clinically apparent vocal fold length changes with AA could be an illusion due to vertical displacement of the vocal process, and not actual lengthening.


Subject(s)
Arytenoid Cartilage/pathology , Arytenoid Cartilage/surgery , Vocal Cord Paralysis/pathology , Vocal Cord Paralysis/surgery , Adult , Arytenoid Cartilage/diagnostic imaging , Cadaver , Humans , Laryngoscopy , Male , Rotation , Tomography, X-Ray Computed , Videotape Recording , Vocal Cord Paralysis/diagnostic imaging
19.
Arch Otolaryngol Head Neck Surg ; 123(6): 641-5, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9193229

ABSTRACT

Five cases of prenatally detected neck masses that had a potential for airway obstruction at birth are described. The various options for management of the airway are discussed, including using maternal-fetal circulation until intubation, rigid bronchoscopy, tracheotomy, cyst aspiration, or extracorporeal membrane oxygen support. Congenital abnormalities involving the fetal face or neck are extremely rare. With technical advances in ultrasonography, these masses were first noted on prenatal ultrasound in the late 1970s. Before that period, they were detected at delivery. These masses are solid or cystic and may cause asphyxia because of airway obstruction at the time of delivery. The survivability of these neonates without immediate intervention at birth is 0% to 20%. If a neck mass is detected in the fetus by prenatal ultrasonography, then a strategic plan for these types of cases should be developed early in the prenatal period. The airway management plan should be tailored for each individual case. Coordination and the expertise of an obstetrician, neonatologist, anesthesiologist, and pediatric otolaryngologist are needed to manage these complex situations.


Subject(s)
Airway Obstruction/diagnostic imaging , Airway Obstruction/prevention & control , Head and Neck Neoplasms , Ultrasonography, Prenatal , Adult , Airway Obstruction/etiology , Bronchoscopy , Delivery, Obstetric/methods , Extracorporeal Membrane Oxygenation , Female , Goiter/complications , Goiter/congenital , Goiter/diagnostic imaging , Goiter/therapy , Head and Neck Neoplasms/complications , Head and Neck Neoplasms/diagnostic imaging , Head and Neck Neoplasms/therapy , Humans , Infant, Newborn , Intubation, Intratracheal , Male , Placental Circulation , Pregnancy , Tracheotomy
20.
Pharmacoeconomics ; 12(1): 76-88, 1997 Jul.
Article in English | MEDLINE | ID: mdl-10169389

ABSTRACT

Clinicians recognise nonsteroidal anti-inflammatory drugs (NSAIDs) as valuable first-line agents in the treatment of rheumatic disorders and as dangerous irritants to the gastrointestinal tract. This has led to questions about the economic impact of NSAID-induced gastropathy in populations. This study estimated the 1992 costs of NSAID-associated gastropathy episodes, and calculated an iatrogenic cost factor for NSAID-associated gastropathy among elderly members of a health maintenance organisation (HMO), the Northwest Region of Kaiser Permanente. Using data retrieved from automated databases and from medical records, NSAID and antiulcer drug costs were calculated, and estimates were made of the incidence rates of inpatient and outpatient NSAID-associated gastropathies, the services provided to treat them, and the cost of those services. Kaiser Permanente Northwest spent $US0.35 for each $US1.00 spent on NSAID therapy for the elderly, an iatrogenic cost factor of 1.35. The estimated average treatment per NSAID-associated gastropathy episode was $US2172. The average outpatient pharmacy cost per elderly NSAID user was $US80 and estimated average NSAID-associated treatment cost per elderly NSAID user was $US43. Although the findings were specific to the HMO because of the databases used, the methodology employed and the drug formulary influence on NSAID selection, they show that a substantial amount of resources were used to treat NSAID-induced gastropathies in the elderly, underscoring the risk of prescribing NSAIDs and reinforcing the need for their prudent use in elderly patients.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/economics , Cost-Benefit Analysis/economics , Gastrointestinal Diseases/chemically induced , Gastrointestinal Diseases/economics , Health Maintenance Organizations/economics , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...